LIVINGSTON, NJ / ACCESSWIRE / May 14, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16, 2019 to discuss the Company’s financial results for the first quarter ended March 31, 2019, as well as the Company’s corporate progress and other developments. The Company also announced it plans to report its earnings results pre-market on Wednesday, May 15, 2019.
The conference call will be available on the Company’s website at www.milestonescientific.com, or via telephone by dialing toll free 800-458-4121 and entering the pass code 4124860. For those unable to participate at that time, a replay of the call will be archived on the company’s website or can be accessed by dialing 888-203-1112 and entering the pass code 4124860. The replay will be available for 90 days.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a medical device company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.
CONTACT:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
SOURCE: Milestone Scientific Inc.
View source version on accesswire.com:
https://www.accesswire.com/545335/Milestone-Scientific-Schedules-First-Quarter-2019-Conference-Call
Consumer report about over-the-counter “phentermine alternative” search behavior, the OTC appetite suppressant market, and how…
SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…
Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…
January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…
The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…